Genomics Strategies for Antifungal Drug Discovery - From Gene Discovery to Compound Screening

Author(s): Debra Aker Willins , Marco Kessler , Scott S. Walker , Gregory R. Reyes , Guillaume Cottarel .

Journal Name: Current Pharmaceutical Design

Volume 8 , Issue 13 , 2002


The use of genomics tools to discover new genes, to decipher pathways or to assign a function to a gene is just beginning to have an impact. Genomics approaches have been applied to both antibacterial and antifungal target discovery in order to identify a new generation of antibiotics. This review discusses genomics approaches for antifungal drug discovery, focusing on the areas of gene discovery, target validation, and compound screening. A variety of methods to identify fungal genes of interest are discussed, as well as methods for obtaining full-length sequences of these genes. One approach is well-suited to organisms having few introns (Candida albicans), and another for organisms with many introns (Aspergillus fumigatus). To validate broad spectrum fungal targets, the yeast Saccharomyces cerevisiae was used as a model system to rapidly identify genes essential for growth and viability of the organism. Validated targets were then exploited for high-throughput compound screening.

Keywords: antifungal, antibacterial, target validation, fungal genes, bacterial genes

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2002
Page: [1137 - 1154]
Pages: 18
DOI: 10.2174/1381612023394890
Price: $58

Article Metrics

PDF: 9